JM keeps selling and putting downward pressure on the stock. Tn Antigen news looks great, will we be welcoming institutions on the register after this announcement? Sequoia Canaccord & Bell Potter have now all initiated coverage.
Sentia revenues will grow over time as UBI claw market share. The revenue opportunities from other sectors such as oncology, covid, vetinary and coagulation will really give the company its blue sky.
Let's see how much the raise is and for what price.
JM keeps selling and putting downward pressure on the stock. Tn...
Add UBI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.005(3.33%) |
Mkt cap ! $35.86M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 15.5¢ | $14.86K | 92.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10650 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 19606 | 1 |
View Market Depth
| Last trade - 15.09pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
16.0¢ |
Change
0.005 ( 10.3 %) |
||||
| Open | High | Low | Volume | ||
| 15.5¢ | 16.0¢ | 15.5¢ | 48789 | ||
| Last updated 10.33am 03/05/2024 ? | |||||
| UBI (ASX) Chart |